Physician profile
James Carinder
NPI 1508821372
$14,004.39
in general payments reported to CMS, 2019-2025
73 companies · $2,447 in 2025
The $2,447 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,928 · 2020: $572 · 2021: $650 · 2022: $1,994 · 2023: $2,619 · 2024: $2,795 · 2025: $2,447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,401 · Education: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,400.91 |
| Education | $459.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,140.69 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,038.78 | 2019-2025 | Opdivo, Opdualag, Augtyro |
| Celgene Corporation | $896.83 | 2019-2025 | Reblozyl, Pomalyst, Opdivo |
| Pfizer INC. | $792.94 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $658.29 | 2019-2025 | Keytruda, Reblozyl, Lynparza |
| Genentech USA, INC. | $576.40 | 2019-2025 | Polivy, Venclexta, Itovebi |
| Genzyme Corporation | $516.45 | 2019-2025 | |
| Janssen Biotech, INC. | $461.67 | 2019-2025 | Darzalex, Tecvayli, Erleada |
| Sanofi-Aventis U.S. LLC | $447.88 | 2020-2025 | |
| Astellas Pharma US INC | $429.21 | 2019-2025 | Vyloy, Cresemba, Padcev |
| Takeda Pharmaceuticals U.S.A., INC. | $400.03 | 2019-2025 | Alunbrig, Fruzaqla, Ninlaro |
| Astrazeneca Pharmaceuticals LP | $361.32 | 2019-2025 | Enhertu, Lynparza, Imfinzi |
| Puma Biotechnology, INC. | $352.68 | 2019-2023 | |
| Amgen INC. | $347.92 | 2019-2023 | Kyprolis, Lumakras, Blincyto |
| Gilead Sciences, INC. | $345.35 | 2021-2025 | Trodelvy |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $330.90 | 2019-2025 | |
| Abbvie INC. | $329.07 | 2019-2025 | Venclexta |
| Lilly USA, LLC | $283.04 | 2019-2023 | Verzenio, Jaypirca |
| Daiichi Sankyo INC. | $280.56 | 2022-2025 | Enhertu, Datroway, Injectafer |
| Exelixis INC. | $269.33 | 2019-2025 | Cabometyx |
| Incyte Corporation | $245.75 | 2019-2025 | Jakafi, Monjuvi |
| Pharmacyclics LLC, An Abbvie Company | $245.08 | 2019-2023 | Imbruvica, Epkinly |
| Aveo Pharmaceuticals, INC. | $244.67 | 2021-2025 | |
| Seagen INC. | $244.66 | 2019-2023 | Adcetris, Tukysa |
| Bayer Healthcare Pharmaceuticals INC. | $208.95 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $184.80 | 2019-2025 | Onivyde, Somatuline Depot, Tazverik |
| Glaxosmithkline, LLC. | $178.32 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Regeneron Healthcare Solutions, INC. | $177.58 | 2019-2025 | Libtayo |
| Beigene USA, INC. | $151.60 | 2021-2025 | Brukinsa |
| Array Biopharma INC | $147.75 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Rigel Pharmaceuticals, INC. | $145.92 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Adaptive Biotechnologies Corporation | $142.24 | 2022-2025 | Clonoseq |
| Kite Pharma, INC. | $95.44 | 2021-2025 | Yescarta |
| Tesaro, INC. | $73.23 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.68 | 2019-2024 | Gilotrif |
| Recordati_rare_diseases_inc. | $64.84 | 2024-2025 | Sylvant |
| Servier Pharmaceuticals LLC | $59.40 | 2024-2025 | |
| Stemline Therapeutics INC. | $58.22 | 2023 | Orserdu |
| Teva Pharmaceuticals USA, INC. | $57.92 | 2019 | |
| G1 Therapeutics, INC. | $52.23 | 2022-2023 | Cosela |
| Clovis Oncology, INC. | $52.09 | 2019 | |
| Springworks Therapeutics, INC. | $48.64 | 2024-2025 | Ogsiveo |
| Myovant Sciences INC. | $47.44 | 2022 | |
| Mirati Therapeutics, INC. | $41.07 | 2023-2024 | Krazati |
| Secura Bio, INC. | $38.78 | 2024 | Copiktra |
| Immunocore Limited | $38.24 | 2025 | Kimmtrak |
| Tempus Ai, INC | $36.88 | 2024-2025 | Xt Cdx |
| Veracyte, INC. | $35.80 | 2023 | |
| Morphosys, US INC. | $35.25 | 2023 | Monjuvi |
| Alnylam Pharmaceuticals INC. | $34.54 | 2022 | |
| Apellis Pharmaceuticals, INC. | $33.51 | 2023 | Empaveli |
| Genmab U.S., INC. | $32.99 | 2022-2025 | Epkinly |
| Blueprint Medicines Corporation | $31.86 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $29.12 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $28.14 | 2025 | Adstiladrin |
| Geron Corporation | $26.13 | 2025 | Rytelo |
| Syndax Pharmaceuticals, INC. | $26.03 | 2025 | |
| Menarini Silicon Biosystems, INC. | $24.48 | 2025 | |
| Kyowa Kirin, INC. | $23.13 | 2019 | |
| Beone Medicines USA, INC. | $22.09 | 2025 | Brukinsa |
| Dendreon Pharmaceuticals LLC | $20.56 | 2025 | Provenge |
| Pharmacosmos Therapeutics INC. | $19.45 | 2024 | Cosela |
| Sumitomo Pharma America, INC. | $19.44 | 2023 | Orgovyx |
| Foundation Medicine, INC. | $16.62 | 2023 | |
| Verastem, INC. | $16.49 | 2019 | |
| Tactile Systems Technology INC | $16.05 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $15.84 | 2019 | |
| Adc Therapeutics America, INC. | $15.65 | 2021 | |
| Emd Serono, INC. | $14.61 | 2019 | |
| Spectrum Pharmaceuticals INC. | $14.28 | 2024 | Rolvedon |
| Janssen Scientific Affairs, LLC | $14.13 | 2019 | |
| Cti Biopharma Corp. | $12.73 | 2023 | Vonjo |
| Karyopharm Therapeutics INC. | $12.71 | 2023 | Xpovio |
Drugs and devices associated with these payments
Reblozyl $584Sarclisa $374Enhertu $324Opdivo $322Tukysa $244Cabometyx $239Keytruda $223Kisqali $209Venclexta $208Lenvima $207Fotivda $192Ibrance $178Epkinly $173Darzalex $166Adcetris $164Imbruvica $162Tecvayli $141Elrexfio $134Braftovi $134Mektovi $134Brukinsa $133Bosulif $127Clonoseq $123Jevtana $122Jakafi $119Trodelvy $110Polivy $110Scemblix $106Fabhalta $105Pluvicto $103Padcev $102Opdualag $102Monjuvi $98.47Libtayo $90.35Lorbrena $89.64Xtandi $87.08Jemperli $76.09Zejula $76.09Rezlidhia $74.61Tavalisse $74.61Yescarta $69.30Stivarga $67.82Vitrakvi $67.82Sylvant $64.84Lynparza $63.92Onivyde $61.83Somatuline Depot $61.83Cablivi $59.84Tibsovo $59.40Krazati $59.20Tasigna $58.69Pomalyst $58.41Orserdu $58.22Ojjaara $56.80Nubeqa $56.66Elahere $55.66Gilotrif $55.53Cosela $54.98Alunbrig $53.45Paxlovid $51.59Talzenna $51.22Orgovyx $50.17Ogsiveo $48.64Comirnaty $48.40Inlyta $48.22Piqray $46.81Itovebi $42.80Mekinist $40.05Besponsa $38.86Copiktra $38.78Kimmtrak $38.24Enjaymo $35.91Erleada $35.15Xofigo $33.63Empaveli $33.51Kyprolis $33.47Promacta $29.63Lutathera $29.48Adstiladrin $28.14Gavreto $27.34Columvi $27.11Lunsumio $27.11Rytelo $26.13Cellsearch $24.48Datroway $24.31Vyloy $22.82Jaypirca $22.73Verzenio $22.73Carvykti $22.50Cresemba $21.89Augtyro $21.83Welireg $21.37Provenge $20.56Xospata $20.56Fruzaqla $20.29Akeega $19.87Balversa $19.87Xalkori $19.86Xt Cdx $19.39Ayvakit $19.25
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Carinder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.